Hg(II) trace electrochemical detection on gold electrode: Evidence for chloride adsorption as the responsible for the broad baseline

Investigations were performed in order to clarify the origin of the broad baseline observed during Hg(II) trace electrochemical detection on gold electrode in the presence of Cl- anions. The influence of Cl- concentration on the shape of the voltammograms was studied in the presence and in the absence of Bovine Serum Albumin (BSA) in order to bring out adsorption/desorption processes. On the basis of these experiments, and contrary to what has been proposed by several authors in the literature, it was proved that the broad baseline does not result from calomel (Hg2Cl2) formation but is rather related to an interaction between Cl- and polycrystalline Au electrode surface. The evolution of the shape of the baseline was also studied in the presence of other halide anions, namely F-, Br-, and I-. The latter two were found to induce a broad baseline similar to that recorded in the presence of Cl-. Finally, it was shown that BSA addition is not suitable for Hg(II) detection since it prevents Hg(0) deposition onto the electrode surface

Influence of the gold nanoparticles electrodeposition method on Hg(II) trace electrochemical detection

Gold nanoparticles (AuNPs) were deposited on Glassy Carbon (GC) substrate by using three electrochemical techniques: Cyclic Voltammetry (CV), Chronoamperometry (CA) and Potentiostatic Double-Pulse (PDP). For each electrodeposition method, the resulting AuNPs-modified electrodes were characterized by CV in H2SO4 and Field Emission Gun Scanning Electron Microscopy (FEG-SEM). CA was found to be the best electrodeposition mode for controlling the morphology and the density of AuNPs. The modified electrodes were used for low Hg(II) concentration detection using Square Wave Anodic Stripping Voltammetry (SWASV). AuNPs obtained by CA afforded the best amperometric response while involving the lowest amount of charge during the electrodeposition step (QAu(III)). This analytical response is correlated to both the smallest particle size (ca. 17 nm in diameter) and the highest particle density (332 particles μm−2), thus displaying high electrode effective surface area. In these optimal conditions, using a Hg(II) preconcentration time of 300 s, the nanosensor array exhibited a linearity range from 0.80 to 9.9 nM with a sensitivity of 1.16 μA nM−1. A detection limit of 0.40 nM (s/n = 3) was reached

Considerations on travelling waves in the horn equation and energetic aspects

International audienceThe digital waveguide synthesis of wind resonators and of the vocal tract is based on decompositions into travelling waves. Typical ones are planar waves in straight pipes and spherical waves in conical pipes. However, approximating a bore by cascading such basic segments introduce unrealistic discontinuities on the radius R or the slope R' (with acoustic consequences). It also can generate artificial instabilities in time-domain simulations, e.g. for non convex junctions of cones. In this paper, we investigate the case of the "conservative curvilinear horn equation" for segments such that the flaring parameter R''/R is constant, with which smooth profiles can be built. First, acoustic states that generalize planar waves and spherical waves are studied. Examining the energy balance and the passivity for these travelling waves allows to characterize stability domains. Second, two other definitions of travelling waves are studied: (a) one locally diagonalizes the wave propagation operator, (b) one diagonalizes the transfer matrix of a segment. The propagators obtained for (a) are known to efficiently factorize computations in simulations but are not stable if the flaring parameter is negative. A study in the Laplace domain reveals that propagators (b) are stable for physically meaningful configurations

Yersinia enterocolitica prevalence and diversity in a pig slaughterhouse

Yersinia enterocolitica is involved in human foodborne infections. Pigs are considered as a major reservoir in many countries. The aim of the study was to contribute to the evaluation of the prevalence of Y. enterocolitica in France in pigs at the slaughterhouse level with optimized detection methods based on ISO 10273-2003

Yersinia enteroco/itica prevalence in a French slaughterhouse: first results

Yersinlia enterocolitica is involved in human foodbome infections. Pigs are considered as a major reservoir in many countries. The aim of the study was to contribute to the evaluation of the prevalence of Y. enterocolitica in France in pigs at the slaughterhouse level with optimized detection methods based on ISO 10273-2003. Several samples of tonsils over nine consecutive months were analyzed in a single slaughterhouse. Enumeration and isolation were achieved by using CIN agar and Y eCM chromogenic medium (modified from the Weagant medium, 2008). Two enrichment media were used: a peptone, sorbitol and biliary salts broth (PSB) and the Irgasan, Ticarcillin and potassium chlorate broth (ITC)

Elastin-Derived Peptides Are New Regulators of Thrombosis

International audienc

The Innate Immune Response in Eisenia Fetida to Microbial Challenges

The common earthworm, Eisenia fetida, exhibits a rudimentary immune system. The earthworm needs cellular and chemical responses against a constant microbial exposure from its natural environment. Some cellular and chemical responses are found in the coelomic fluid and have been shown to demonstrate anti-microbial characteristics. This project uses microscopy and modified staining techniques to differentiate and categorize the cellular components found in the coelomic fluid. Following a microbial challenge by Klebsiella pneumoniae, an inflammatory response was initiated. Six groups of earthworms were injected with 0.05 ml of 1.0 x 106 cfu /ml K. pneumoniae on day one and tested over a period of five days. A group of three worms was shocked each day for the next five days to cause the coelomic fluid and cells to pass through the body wall. The coelomic fluid was placed directly on glass slides, dried and stained with a modified Wright’s stain using a wash buffer solution with a pH of 6.3. The stained cells were differentiated into four categories. Total cell counts were determined. The data indicated a marked proliferation in total cell counts in comparison to the control worms. This trend of increasing total cell counts continued over the five days. The percent ages of the four types of coelomic cells from the differential remained constant. Cells were photographed and documented for comparisons. Additional studies are ongoing to determine how long the Eisenia fetida take to remove Klebsiella pneumoniae from the coelomic cavity

Prenatal and Early Postnatal Diagnosis of Congenital Toxoplasmosis in a Setting With No Systematic Screening in Pregnancy

To determine the risk of congenital toxoplasmosis (CT) and provide early (pre-or postnatal) identification of cases of CT in the absence of systematic screening in pregnancy. In the presented cross-sectional study, serological criteria were used to date Toxoplasma gondii infection versus conception in 80 pregnant women with fetal abnormalities or referred to as suspected of acute infection, and in 16 women after delivery of symptomatic neonates. A combination of serological, molecular (qPCR), and biological (bioassay) methods was used for prenatal and/or postnatal diagnosis of CT. Most (77.5%) pregnant women were examined in advanced pregnancy. Of all the examined seropositive women (n = 90), infection could not be ruled out to have occurred during pregnancy in 93.3%, of which the majority (69%) was dated to the periconceptual period. CT was diagnosed in 25 cases, of which 17 prenatally and 8 postnatally. Molecular diagnosis proved superior, but the diagnosis of CT based on bioassay in 7 instances and by Western blot in 2 neonates shows that other methods remain indispensable. In the absence of systematic screening in pregnancy, maternal infection is often diagnosed late, or even only when fetal/neonatal infection is suspected. In such situations, use of a complex algorithm involving a combination of serological, biological, and molecular methods allows for prenatal and/or early postnatal diagnosis of CT, but lacks the preventive capacity provided by early maternal treatment

Characterization of Ceftazidime Resistance Mechanisms in Clinical Isolates of Burkholderia pseudomallei from Australia

Burkholderia pseudomallei is a Gram-negative bacterium that causes the serious human disease, melioidosis. There is no vaccine against melioidosis and it can be fatal if not treated with a specific antibiotic regimen, which typically includes the third-generation cephalosporin, ceftazidime (CAZ). There have been several resistance mechanisms described for B. pseudomallei, of which the best described are amino acid changes that alter substrate specificity in the highly conserved class A β-lactamase, PenA. In the current study, we sequenced penA from isolates sequentially derived from two melioidosis patients with wild-type (1.5 µg/mL) and, subsequently, resistant (16 or ≥256 µg/mL) CAZ phenotypes. We identified two single-nucleotide polymorphisms (SNPs) that directly increased CAZ hydrolysis. One SNP caused an amino acid substitution (C69Y) near the active site of PenA, whereas a second novel SNP was found within the penA promoter region. In both instances, the CAZ resistance phenotype corresponded directly with the SNP genotype. Interestingly, these SNPs appeared after infection and under selection from CAZ chemotherapy. Through heterologous cloning and expression, and subsequent allelic exchange in the native bacterium, we confirmed the role of penA in generating both low-level and high-level CAZ resistance in these clinical isolates. Similar to previous studies, the amino acid substitution altered substrate specificity to other β-lactams, suggesting a potential fitness cost associated with this mutation, a finding that could be exploited to improve therapeutic outcomes in patients harboring CAZ resistant B. pseudomallei. Our study is the first to functionally characterize CAZ resistance in clinical isolates of B. pseudomallei and to provide proven and clinically relevant signatures for monitoring the development of antibiotic resistance in this important pathogen

An international comparative analysis and roadmap to sustainable biosimilar markets

Background: Although biosimilar uptake has increased (at a variable pace) in many countries, there have been recent concerns about the long-term sustainability of biosimilar markets. The aim of this manuscript is to assess the sustainability of policies across the biosimilar life cycle in selected countries with a view to propose recommendations for supporting biosimilar sustainability.Methods: The study conducted a comparative analysis across 17 countries from North America, South America, Asia-Pacific, Europe and the Gulf Cooperation Council. Biosimilar policies were identified and their sustainability was assessed based on country-specific reviews of the scientific and grey literature, validation by industry experts and 23 international and local non-industry experts, and two advisory board meetings with these non-industry experts.Results: Given that European countries tend to have more experience with biosimilars and more developed policy frameworks, they generally have higher sustainability scores than the other selected countries. Existing approaches to biosimilar manufacturing and R&D, policies guaranteeing safe and high-quality biosimilars, exemption from the requirement to apply health technology assessment to biosimilars, and initiatives counteracting biosimilar misconceptions are considered sustainable. However, biosimilar contracting approaches, biosimilar education and understanding can be ameliorated in all selected countries. Also, similar policies are sometimes perceived to be sustainable in some markets, but not in others. More generally, the sustainability of the biosimilar landscape depends on the nature of the healthcare system and existing pharmaceutical market access policies, the experience with biosimilar use and policies. This suggests that a general biosimilar policy toolkit that ensures sustainability does not exist, but varies from country to country.Conclusion: This study proposes a set of elements that should underpin sustainable biosimilar policy development over time in a country. At first, biosimilar policies should guarantee the safety and quality of biosimilars, healthy levels of supply and a level of cost savings. As a country gains experience with biosimilars, policies need to optimise uptake and combat any misconceptions about biosimilars. Finally, a country should implement biosimilar policies that foster competition, expand treatment options and ensure a sustainable market environment